Basak P, Sadhukhan P, Sarkar P, Sil PC. Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy [J]. Toxicol Rep. 2017;4:306–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boulos N, Mulder HL, Calabrese CR, Morrison JB, Rehg JE, Relling MV, Sherr CJ, Williams RT. Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia [J]. Blood. 2011;117(13):3585–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen D, Wu Y-X, Qiu Y-B, Wan B-B, Liu G, Chen J-L, Lu M-D, Pang Q-F. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis [J]. Phytomedicine. 2020;67:153138.

Article  CAS  PubMed  Google Scholar 

Chen X, Yu C, Kang R, Kroemer G, Tang D. Cellular degradation systems in ferroptosis [J]. Cell Death Differ. 2021;28(4):1135–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Zhao Y, Wang X, Zang L, Yin D, Tan S. Hyperoside inhibits RNF8-mediated nuclear translocation of β-catenin to repress PD-L1 expression and prostate Cancer [J]. Anticancer Agents Med Chem. 2024;24(6):464–76.

Article  CAS  PubMed  Google Scholar 

de la Rojo M, Chapman E, Zhang DD. NRF2 and the hallmarks of Cancer [J]. Cancer Cell. 2018;34(1):21–43.

Article  Google Scholar 

Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis [J]. Redox Biol. 2019;23:101107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, N, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J]. N Engl J Med. 2006;355(23):2408–17.

Article  CAS  PubMed  Google Scholar 

Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis [J]. Proteomics. 2019;19(18):e1800311.

Article  PubMed  Google Scholar 

Fu T, Wang L, Jin X-n, Sui H-j, Liu Z, Jin Y. Hyperoside induces both autophagy and apoptosis in non-small cell lung cancer cells in vitro [J]. Acta Pharmacol Sin. 2016;37(4):505–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo W, Yu H, Zhang L, Chen X, Liu Y, Wang Y, Zhang Y. Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes [J]. Cancer Cell Int. 2019;19:235.

Article  PubMed  PubMed Central  Google Scholar 

Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H, Hughes TP, Janssen JJWM, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Mayer J, Nicolini F, Niederwieser D, Pane F, Radich JP, Rea D, Richter J, Rosti G, Rousselot P, Saglio G, Saußele S, Soverini S, Steegmann JL, Turkina A, Zaritskey A, Hehlmann R. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia [J]. Leukemia. 2020;34(4):966–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imai H, Matsuoka M, Kumagai T, Sakamoto T, Koumura T. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis [J]. Curr Top Microbiol Immunol. 2017;403:143–70.

CAS  PubMed  Google Scholar 

Jabbour E, Short NJ, Jain N, Huang X, Montalban-Bravo G, Banerjee P, Rezvani K, Jiang X, Kim KH, Kanagal-Shamanna R, Khoury JD, Patel K, Kadia TM, Daver N, Chien K, Alvarado Y, Garcia-Manero G, Issa GC, Haddad F, Kwari G, Thankachan M, Delumpa J, Macaron R, Garris W, Konopleva R, Ravandi M, Kantarjian F. Ponatinib and Blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial [J]. Lancet Haematol. 2023;10(1):e24–34.

Article  CAS  PubMed  Google Scholar 

Jia M, Qin D, Zhao C, Chai L, Yu Z, Wang W, Tong L, Lv L, Wang Y, Rehwinkel J, Yu J, Zhao W. Redox homeostasis maintained by GPX4 facilitates STING activation [J]. Nat Immunol. 2020;21(7):727–35.

Article  CAS  PubMed  Google Scholar 

Khan HY, Zubair H, Ullah MF, Ahmad A, Hadi SM. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols [J]. Curr Drug Targets. 2012;13(14):1738–49.

Article  CAS  PubMed  Google Scholar 

Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment [J]. Trends Pharmacol Sci. 2023;44(8):542–52.

Article  CAS  PubMed  Google Scholar 

Koppula P, Zhang Y, Zhuang L, Gan B. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer [J]. Cancer Commun (Lond). 2018;38(1):12.

PubMed  Google Scholar 

Li W, Liu M, Xu Y-F, Feng Y, Che J-P, Wang G-C, Zheng J-H. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a [J]. Oncol Rep. 2014;31(1):117–24.

Article  CAS  PubMed  Google Scholar 

Li J, Jia Y-C, Ding Y-X, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks [J]. Int J Biol Sci. 2023;19(9):2756–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang C, Zhang X, Yang M, Dong X. Recent progress in Ferroptosis Inducers for Cancer therapy [J]. Adv Mater. 2019;31(51):e1904197.

Article  PubMed  Google Scholar 

Lin Y-S, Shen Y-C, Wu C-Y, Tsai Y-Y, Yang Y-H, Lin Y-Y, Kuan F-C, Lu C-N, Chang G-H, Tsai M-S, Hsu C-M, Yeh R-A, Yang P-R, Lee IY, Shu L-H, Cheng Y-C, Liu H-T, Wu Y-H, Wu Y-H, Chang D-C. Danshen improves survival of patients with breast Cancer and dihydroisotanshinone I induces ferroptosis and apoptosis of breast Cancer cells [J]. Front Pharmacol. 2019;10:1226.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Liu G, Liu X, Li S. The effects of hyperoside on apoptosis and the expression of Fas/FasL and survivin in SW579 human thyroid squamous cell carcinoma cell line [J]. Oncol Lett. 2017;14(2):2310–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer [J]. Pharmacol Rev. 2000;52(4):673–751.

CAS  PubMed  Google Scholar 

Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism [J]. Trends Cell Biol. 2023;33(12):1077–87.

Article  CAS  PubMed  Google Scholar 

Qiu J, Zhang T, Zhu X, Yang C, Wang Y, Zhou N, Ju B, Zhou T, Deng G, Qiu C. Hyperoside induces breast Cancer cells apoptosis via ROS-Mediated NF-κB signaling pathway [J]. Int J Mol Sci, 2019, 21(1).

Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M, Bannai S. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression [J]. J Biol Chem. 2002;277(47):44765–71.

Article  CAS  PubMed  Google Scholar 

Shanmugam MK, Warrier S, Kumar AP, Sethi G, Arfuso F. Potential role of natural compounds as anti-angiogenic agents in Cancer [J]. Curr Vasc Pharmacol. 2017;15(6):503–19.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(1).

Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides [J]. J Natl Cancer Inst. 1997;89(2):124–33.

Article  CAS  PubMed  Google Scholar 

Stockwell BR, Jiang X, Gu W. Emerging mechanisms and Disease Relevance of ferroptosis [J]. Trends Cell Biol. 2020;30(6):478–90.

Article